Revision 3

#95546Store at -20C

Cell Signaling Technology

Orders: 877-616-CELL (2355) [email protected]

Support: 877-678-TECH (8324)

Web: [email protected] cellsignal.com

3 Trask LaneDanversMassachusetts01923USA
For Research Use Only. Not for Use in Diagnostic Procedures.
Applications:

WB, IHC-P

REACTIVITY:

M

SENSITIVITY:

Endogenous (IHC-P), Transfected (W)

MW (kDa):

58

Source/Isotype:

Rabbit IgG

UniProt ID:

#Q91WW7

Entrez-Gene Id:

116939

Product Information

Product Usage Information

Application Dilution
Western Blotting 1:1000
Immunohistochemistry (Paraffin) 1:150 - 1:600

Storage

Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/mL BSA, 50% glycerol, and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.

For a carrier free (BSA and azide free) version of this product see product #49662.

Specificity / Sensitivity

PNPLA3 (E7N6O) Rabbit mAb recognizes transfected levels of total PNPLA3 protein by western blot and endogenous levels of total PNPLA3 protein by immunohistochemistry.

Species Reactivity:

Mouse

Species predicted to react based on 100% sequence homology

Rat

Source / Purification

Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Val184 of murine PNPLA3 protein.

Background

PNPLA3, also known as adiponutrin, is a protein encoded by the PNPLA3 gene. It is a member of the patatin-like phospholipase domain (PNPLA) family of proteins, which are involved in various lipid metabolic processes. PNPLA3 is expressed primarily in the liver and adipose tissue, where it is localized to lipid droplets (1). PNPLA3 is also associated with several diseases, including nonalcoholic fatty liver disease (NAFLD). NAFLD is a spectrum of liver diseases that can range from simple steatosis (fatty liver) to nonalcoholic steatohepatitis (NASH), cirrhosis, and hepatocellular carcinoma (HCC) (2). PNPLA3 is the strongest genetic risk factor for NAFLD and its associated complications (3). Mouse PNPLA3 is a valuable tool for studying the role of PNPLA3 in human health and disease (4).

  1. Rotman, Y. et al. (2010) Hepatology 52, 894-903.
  2. Harrison, S.A. and Diehl, A.M. (2002) Semin Gastrointest Dis 13, 3-16.
  3. Speliotes, E.K. et al. (2010) Hepatology 52, 904-12.
  4. Smagris, E. et al. (2015) Hepatology 61, 108-18.

Species Reactivity

Species reactivity is determined by testing in at least one approved application (e.g., western blot).

Western Blot Buffer

IMPORTANT: For western blots, incubate membrane with diluted primary antibody in 5% w/v BSA, 1X TBS, 0.1% Tween® 20 at 4°C with gentle shaking, overnight.

Applications Key

WB: Western Blotting IHC-P: Immunohistochemistry (Paraffin)

Cross-Reactivity Key

H: human M: mouse R: rat Hm: hamster Mk: monkey Vir: virus Mi: mink C: chicken Dm: D. melanogaster X: Xenopus Z: zebrafish B: bovine Dg: dog Pg: pig Sc: S. cerevisiae Ce: C. elegans Hr: horse GP: Guinea Pig Rab: rabbit All: all species expected

Trademarks and Patents

Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
All other trademarks are the property of their respective owners. Visit cellsignal.com/trademarks for more information.

Limited Uses

Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.

Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.

Revision 3
#95546

PNPLA3 (E7N6O) Rabbit mAb

Western Blotting Image 1: PNPLA3 (E7N6O) Rabbit mAb Expand Image
Western blot analysis of extracts from 293T cells, mock transfected (lane 1) or transiently transfected with an expression construct encoding Myc/DDK-tagged PNPLA3 (lane 2), using PNPLA3 (E7N6O) Rabbit mAb (upper), DYKDDDDK Tag (D6W5B) Rabbit mAb #14793 (middle), or β-Actin (D6A8) Rabbit mAb #8457 (lower).
Immunohistochemistry Image 1: PNPLA3 (E7N6O) Rabbit mAb Expand Image
Immunohistochemical analysis of paraffin-embedded mouse stomach using PNPLA3 (E7N6O) Rabbit mAb.
Immunohistochemistry Image 2: PNPLA3 (E7N6O) Rabbit mAb Expand Image
Immunohistochemical analysis of paraffin-embedded mouse brown fat using PNPLA3 (E7N6O) Rabbit mAb.
Immunohistochemistry Image 3: PNPLA3 (E7N6O) Rabbit mAb Expand Image
Immunohistochemical analysis of paraffin-embedded mouse thymus using PNPLA3 (E7N6O) Rabbit mAb.
Immunohistochemistry Image 4: PNPLA3 (E7N6O) Rabbit mAb Expand Image
Immunohistochemical analysis of paraffin-embedded mouse cerebellum using PNPLA3 (E7N6O) Rabbit mAb.
Immunohistochemistry Image 5: PNPLA3 (E7N6O) Rabbit mAb Expand Image
Immunohistochemical analysis of paraffin-embedded mouse lung using PNPLA3 (E7N6O) Rabbit mAb.
Immunohistochemistry Image 6: PNPLA3 (E7N6O) Rabbit mAb Expand Image
Immunohistochemical analysis of paraffin-embedded CT26 syngeneic tumor using PNPLA3 (E7N6O) Rabbit mAb.
Immunohistochemistry Image 7: PNPLA3 (E7N6O) Rabbit mAb Expand Image
Immunohistochemical analysis of paraffin-embedded mouse liver using PNPLA3 (E7N6O) Rabbit mAb (left) compared to concentration-matched Rabbit (DA1E) mAb IgG XP® Isotype Control #3900 (right).
Immunohistochemistry Image 8: PNPLA3 (E7N6O) Rabbit mAb Expand Image
Immunohistochemical analysis of paraffin-embedded 293T cell pellet, untransfected (left) or mouse pnpla3-transfected (right), using PNPLA3 (E7N6O) Rabbit mAb.